DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation

J Cell Physiol. 2015 May;230(5):1094-103. doi: 10.1002/jcp.24841.

Abstract

DNA-dependent protein kinase catalytic subunit (DNA-PKcs) plays a critical role in non-homologous end-joining repair of DNA double-strand breaks (DSB) induced by ionizing radiation (IR). Little is known, however, regarding the relationship between DNA-PKcs and IR-induced angiogenesis; thus, in this study we aimed to further elucidate this relationship. Our findings revealed that lack of DNA-PKcs expression or activity sensitized glioma cells to radiation due to the defective DNA DSB repairs and inhibition of phosphorylated Akt(Ser473) . Moreover, DNA-PKcs deficiency apparently mitigated IR-induced migration, invasion and tube formation of human microvascular endothelial cell (HMEC-1) in conditioned media derived from irradiated DNA-PKcs mutant M059J glioma cells or M059K glioma cells that have inhibited DNA-PKcs kinase activity due to the specific inhibitor NU7026 or siRNA knockdown. Moreover, IR-elevated vascular endothelial growth factor (VEGF) secretion was abrogated by DNA-PKcs suppression. Supplemental VEGF antibody to irradiated-conditioned media was negated enhanced cell motility with a concomitant decrease in phosphorylation of the FAK(Try925) and Src(Try416) . Furthermore, DNA-PKcs suppression was markedly abrogated in IR-induced transcription factor hypoxia inducible factor-1α (HIF-1α) accumulation, which is related to activation of VEGF transcription. These findings, taken together, demonstrate that depletion of DNA-PKcs in glioblastoma cells at least partly suppressed IR-inflicted migration, invasion, and tube formation of HMEC-1 cells, which may be associated with the reduced HIF-1α level and VEGF secretion. Inhibition of DNA-PKcs may be a promising therapeutic approach to enhance radio-therapeutic efficacy for glioblastoma by hindering its angiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms / blood supply*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / radiotherapy
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Movement / radiation effects
  • Chromones / pharmacology
  • Culture Media, Conditioned / pharmacology
  • DNA Breaks, Double-Stranded / drug effects
  • DNA Breaks, Double-Stranded / radiation effects
  • DNA Repair / drug effects
  • DNA Repair / radiation effects
  • DNA-Activated Protein Kinase / antagonists & inhibitors
  • DNA-Activated Protein Kinase / deficiency*
  • DNA-Activated Protein Kinase / metabolism
  • Endothelial Cells / drug effects
  • Endothelial Cells / pathology
  • Endothelial Cells / radiation effects
  • Glioblastoma / blood supply*
  • Glioblastoma / pathology
  • Glioblastoma / radiotherapy
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Morpholines / pharmacology
  • Neoplasm Invasiveness
  • Neovascularization, Pathologic / etiology*
  • Neovascularization, Pathologic / prevention & control*
  • Neovascularization, Physiologic / drug effects
  • RNA, Small Interfering / metabolism
  • Radiation Tolerance / drug effects
  • Radiation Tolerance / radiation effects
  • Radiation, Ionizing*
  • Signal Transduction / drug effects
  • Signal Transduction / radiation effects
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • 2-(morpholin-4-yl)benzo(h)chromen-4-one
  • Chromones
  • Culture Media, Conditioned
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Morpholines
  • RNA, Small Interfering
  • Vascular Endothelial Growth Factor A
  • DNA-Activated Protein Kinase